HNWAG
NXTC icon

High Net Worth Advisory Group’s NextCure NXTC Stock Holding History

High Net Worth Advisory Group’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-42
Closed -$2K – 706
2022
Q1 		$2K Hold
42
– – ﹤0.01% 644
2021
Q4 		$3K Buy
+42
New +$3.51K ﹤0.01% 637

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

High Net Worth Advisory Group's NXTC Position: Q2 2022 in Review

High Net Worth Advisory Group sold out of NextCure (NXTC) in Q2 2022, closing a stake of 42 shares — an estimated $2K sold.

High Net Worth Advisory Group first reported a position in NXTC in Q4 2021 and held it in 2 quarters. The position peaked at $3K in Q4 2021. 51 funds tracked by Wall St. Rank hold NXTC as of Q2 2022.

  • High Net Worth Advisory Group reported no remaining NextCure position as of Q2 2022 after selling out during the quarter.
  • High Net Worth Advisory Group sold 42 NextCure shares in Q2 2022, an estimated $2K.
  • High Net Worth Advisory Group first reported a position in NextCure in Q4 2021 and held it in 2 quarters.
  • High Net Worth Advisory Group's NextCure position peaked at $3K in Q4 2021.
  • 51 funds tracked by Wall St. Rank held NextCure as of Q2 2022.

Based on High Net Worth Advisory Group's 13F filing for Q2 2022, filed 10 Aug 2022.